Contemporary results of focal therapy for prostate cancer using cryoablation

Journal of Endourology

Volumn 24, Issue 5, 2010, Pages 827-834

  Mouraviev, Vladimir ^a   Johansen, Truls Erik Bjerklund ^b   Polascik, Thomas J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER CONTROL; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER THERAPY; CARCINOGENESIS; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CLINICAL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; CRYOABLATION; ERADICATION THERAPY; EVIDENCE BASED MEDICINE; FOLLOW UP; GLEASON SCORE; HEALTH CARE QUALITY; HUMAN; LYMPH NODE METASTASIS; MINIMALLY INVASIVE SURGERY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVIEW; RISK ASSESSMENT; TREATMENT INDICATION; TREATMENT PLANNING;

CRYOSURGERY; HUMANS; MALE; PATIENT SELECTION; PROSTATIC NEOPLASMS; TREATMENT OUTCOME;

EID: 77952576303     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.0546     Document Type: Review

References (52)

1. Bostwick DG, Waters DJ, Farley ER, et al. Group consensus reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006. Urology 2007;70(suppl 6):42-44.
2. Meiers I, Waters DJ, Bostwick DG. Preoperative prediction of multifocal prostate cancer and application of focal therapy: Review 2007. Urology 2007;70(suppl 6):3-8.
3. Polascik TJ, Mouraviev V. Focal therapy for prostate cancer. Curr Opin Urol 2008;18:269-274.
4. Barqawi AB, Crawford ED. The current use and future trends of focal surgical therapy in the management of localized prostate cancer. Cancer J 2007;13:313-317.
5. Mouraviev V, Mayes JM, Sun L, et al. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer 2007; 110:906-910.
6. Polascik TJ, Mayes JM, Sun L, et al. Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: Implications for unilateral ablative therapy. Prostate 2008;68:1380-1386.
7. D'Amico AV, Moul J, Carroll PR, et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostatespecific antigen era. J Clin Oncol 2003;21:2163-2172.
8. Miller DC, Gruber SB, Hollenbeck BK, et al. Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst 2006;98:1134-1141.
9. De La Rosette J, Ahmed H, Barentsz J, et al. Focal therapy in prostate cancer-report from a consensus panel. J Endourol 2010;24:775-780.
10. Bahn DK, Silverman P, Lee F Sr, et al. Focal prostate cryoablation: Initial results show cancer control and potency preservation. J Endourol 2006;20:688-692.
11. Onik G, Vaughan D, Lotenfoe R, et al. "Male lumpectomy": Focal therapy for prostate cancer using cryoablation. Urology 2007;70(suppl 6):16-21.
12. Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: Encouraging health outcomes for unifocal prostate cancer. Urology 2007;69:1117-1120.
13. Ellis DS, Manny TB Jr, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: Initial results. Urology 2007;70 (suppl 6):9-15.
14. Sartor AO, Hricak H, Wheeler TM, et al. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology 2008;72(suppl 6):S12-S24.
15. Partin AW, Mangold LA, Lamm DM, et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001;58:843-848.
16. Kattan MW, Eastham JA, Stapleton AM, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998;90: 766-771.
17. Polascik TJ, Mayes JM, Schroeck FR, et al. Patient selection for hemiablative focal therapy of prostate cancer: Variables predictive of tumor unilaterality based upon radical prostatectomy. Cancer 2009;115:2104-2110.
18. Iczkowski KA, Hossain D, Torkko KC, et al. Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. Urology 2008;71:1166-1171.
19. Tareen B, Sankin A, Godoy G, et al. Appropriate candidates for hemiablative focal therapy are infrequently encountered among men selected for radical prostatectomy in contemporary cohort. Urology 2009;73:351-355.
20. Yoon GS, Wang W, Osunkoya AO, et al. Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urol 2008;179:2203-2206.
21. Andriole GL, Bullock TL, Belani JS, et al. Is there a better way to biopsy the prostate? Prospects for a novel transrectal systematic biopsy approach. Urology 2007;70(suppl 6):22-26.
22. Boccon-Gibod LM, De Longchamps NB, Toublanc M, et al. Prostate saturation biopsy in the reevaluation of microfocal prostate cancer. J Urol 2006;176:961-964.
23. Graser A, Heuck A, Sommer B, et al. Per-sextant localization and staging of prostate cancer: Correlation of imaging findings with whole-mount step section histopathology. AJR Am J Roentgenol 2007;188:84-90.
24. Onik G, Barzell W. Transperineal 3D mapping biopsy of the prostate: An essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 2008;26:506-510.
25. Barzell WE, Melamed MR. Appropriate patient selection in the focal treatment of prostate cancer: The role of transperineal 3-dimensional pathologic mapping of the prostate-a 4-year experience. Urology 2007;70(suppl 6):27-35.
26. Crawford ED, Barqawi A. Targeted focal therapy: A minimally invasive ablation technique for early prostate cancer. Oncology (Williston Park) 2007;21:27-39.
27. Mayes J, Mouraviev V, Sun L, et al. Can the conventional sextant prostate biopsy reliably diagnose unilateral prostate cancer in low-risk, localized, prostate cancer? Urol Oncol 2009; May 16. E-pub ahead of print.
28. Barber T, Pansare V, Nikolavsky D, et al. Pathologic characteristics of contralateral prostate cancer among patients with a single positive core. J Urol 2006;175(suppl);507. Abstract 1573.
29. Presti JC. Prostate biopsy: Current status and limitations. Rev Urol 2007;9:93-98.
30. Ravery V, Dominique S, Panhard X, et al. The 20-core prostate biopsy protocol-a new gold standard? J Urol 2008;179:504-507.
31. Jones JS. Saturation biopsy for detecting and characterizing prostate cancer. BJU Int 2007;99:1340-1344.
32. Barqawi A, Arangua PR, ED C. The role of 3D mapping biopsy of the prostate in decision making for treatment of early stage prostate cancer. Abstracts of the American Urological Association annual meeting. April 25-30, 2009; Chicago, IL. J Urol 2009;181(suppl 4):717. Abstract 1979.
33. Onik G, Narayan P, Vaughan D, et al. Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: A new approach to preserving potency. Urology 2002;60:109-114.
34. Janzen NK, Han KR, Perry KT, et al. Feasibility of nervesparing prostate cryosurgery: Applications and limitations in a canine model. J Endourol 2005;19:520-525.
35. Mouraviev V, Polascik TJ. Avoiding surgery in prostate cancer patients with low-risk disease. Future Medicine. Therapy 2008;5:25-36.
36. Cresswell J, Asterling S, Chaudhary M, et al. Thirdgeneration cryotherapy for prostate cancer in the UK: A prospective study of the early outcomes in primary and recurrent disease. BJU Int 2006;97:969-974.
37. Miller R, Cohen JJ. Prostate cryosurgery. In: Rukstalis DB, Katz AE, eds. Handbook of Urologic Cryoablation. London: Informa. UK Ltd. 2007:39-46.
38. Polascik TJ, Nosnik I, Mayes JM, Mouraviev V. Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urology 2007;70:117-121.
39. Polascik TJ, Mayes JM, Mouraviev V. From whole-gland to targeted cryoablation for the treatment of unilateral or focal prostate cancer. Oncology (Williston Park) 2008;22:900-914.
40. Ahmed HU, Emberton M. Active surveillance and radical therapy in prostate cancer: Can focal therapy offer the middle way? World J Urol 2008;26:457-467.
41. Eggener SE, Scardino PT, Carroll PR, et al; International ask Force on Prostate Cancedr and the Focal Lesion Paradigm. Focal therapy for localized prostate cancer: A critical appraisal of rationale and modalities. J Urol 2007;178:2260-2267.
42. Jones JS. Focal or subtotal therapy for early stage prostate cancer. Curr Treat Options Oncol 2007;8:165-172.
43. Ahmed HU, Pendse D, Illing R, et al. Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 2007;4:632-642.
44. Tareen B, Godoy G, Sankin A, et al. Laterality alone should not drive selection of candidates for hemi-ablative focal therapy. J Urol 2009;181:1082-1090.
45. Weckermann D, Holl G, Dorn R, et al. Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer. BJU Int 2007;99:1036-1040.
46. Ward JF, Nakanishi H, Pisters L, et al. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy. BJU Int 2009;104: 490-497.
47. Onik G, Vaughan D, Lotenfoe R, et al. The "male lumpectomy": Focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 2008;26:500-505.
48. ASTRO. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1035- 1041.49.
49. Dhar N, Cher ML, Scionti SM, et al. Focal=partial gland prostate cryoablation: Results of 795 patients from multiple centers tracked with the COLD registry. Abstracts of the American Urological Association annual meeting. April 25- 30, 2009; Chicago, IL. J Urol 2009;181(suppl 4):715. Abstract 1975.
50. Roach III M, Hanks G, Thames H Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006;65: 965-974.
51. Rukstalis DB, Goldknopf JL, Crowley EM, Garcia FU. Prostate cryoablation: A scientific rationale for future modifications. Urology 2002;60(suppl 1):19-25.
52. Johnstone PA, Rossi PJ, Jani AB, Master V. 'Insignificant' prostate cancer on biopsy: Pathologic results from subsequent radical prostatectomy. Prostate Cancer Prostatic Dis 2007;10:237-241.